摘要
目的构建促红细胞生成素(EPO)表达质粒,并在人近端肾小管上皮细胞中稳定表达。方法应用标准分子克隆技术构建EPO真核表达载体pcDNA3.1(-)-hEPO。磷酸钙法转染人肾小管近端上皮细胞(HK-2)。酶联免疫吸附法(ELISA)检测培养液上清中的EPO含量。MTT法绘制各组细胞生长曲线。结果构建获得EPO基因的表达质粒,并成功转染肾小管上皮细胞,后者经G418筛选,稳定表达EPO。转染后第21天,其表达量为同期转染的293细胞的(35.0±5.3)%。转染后HK-2细胞生长曲线未见明显改变。结论人近端肾小管上皮细胞可以稳定表达EPO,这为EPO基因治疗选择新靶点奠定了基础。
Objective To stably express human erythropoietin (EPO) gene in human proximal tubular epithelial cells (HK-2). Methods Eukaryotic expression vector for human EPO gene was constructed by the standard molecular cloning method. The recombinant pcDNA3.1 (-)-hEPO vector was transfected to 293 cells and HK-2 cells by the calcium phosphate coprecipitation method. EPO in cultured supernatant was detected by ELISA. Proliferation of HK-2 cells was assayed by MTT method. Results After successful construction of the recombinant plasmid and transfection of the plasmid to HK-2 cells, EPO was temporarily expressed in transfected HK-2 cells, and was constantly expressed in ttansfected HK-2 after selection by G418. The expression level of EPO in transfectcd HK- 2 cells was (35.0±5.3)% of that in transfected 293 cells. HK-2 cells stably expressing transfected human EPO did not show any changes of cell growth. Conclusion Human EPO cDNA can be stably expressed in human proximal tubular epithelial cells (HK-2), suggesting a promising approach for EPO gene therapy.
出处
《中国血液净化》
2009年第4期211-214,共4页
Chinese Journal of Blood Purification
基金
中华人民共和国人事部留学人员择优基金(2007170)
关键词
促红细胞生成素
近端肾小管上皮细胞
基因转染
基因表达
Erythropoietin
Human proximal tubular epithelial cells(HK-2 cells)
Gene transfection
Gene expression